Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: NovaBay Pharmaceuticals Q2 Earnings

  NovaBay Pharmaceuticals (AMEX:NBY) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
byBenzinga Insights
August 12, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

 

NovaBay Pharmaceuticals (AMEX:NBY) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

NovaBay Pharmaceuticals missed estimated earnings by 33.33%, reporting an EPS of $-0.04 versus an estimate of $-0.03.

Revenue was up $912 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.02 which was followed by a 5.21% increase in the share price the next day.

 

To track all earnings releases for NovaBay Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Nutanix: Q3 Earnings Insights

By Benzinga Insights
May 25, 4:48 PM
Nutanix (NASDAQ:NTNX) reported its Q3 earnings results on Wednesday, May 25, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Nutanix beat estimated earnings by 77.27%, reporting an EPS of $-0.05 versus an estimate of $-0.22.

NTNX